Tysabri Touch Form Pdf. Web the touch prescribing program has designed to: Web tysabri increases your risk of getting a rare brain infection—called progressive multifocal leukoencephalopathy (pml)—that most leads to death instead severe disability.
Tysabri Treatment Profile
Web when your doctor writes you a prescription for tysabri, both of you will review, complete, and sign the enrollment form for the touch prescribing program. Web •have you sign the touch® patient enrollment form what is tysabri? Maintain compliance with the touch prescribing program. Tysabri increases the risk of pml. Web current as of 6/1/2013. Tysabri increases the risk of pml Web per the requirements of the touch prescribing program, authorized infusion sites must: Information prescribers, infusion center healthcare providers, and patients with the risk of progressive multifocal leukoencephalopathy (pml) associated with tysabri including the increased risk of pml with treatment duration and prior immunosuppressant use. Although you have been receiving tysabri for 2 years, it is important that you are reminded that the risk of pml increases beyond this time. Streamline communication to/from prescribers and infusion sites.
Web when your doctor writes you a prescription for tysabri, both of you will review, complete, and sign the enrollment form for the touch prescribing program. Although you have been receiving tysabri for 2 years, it is important that you are reminded that the risk of pml increases beyond this time. Reduce administrative burden/paperwork for prescribers and infusion sites. Information prescribers, infusion center healthcare providers, and patients with the risk of progressive multifocal leukoencephalopathy (pml) associated with tysabri including the increased risk of pml with treatment duration and prior immunosuppressant use. Web per the requirements of the touch prescribing program, authorized infusion sites must: Web •have you sign the touch® patient enrollment form what is tysabri? This is to make sure that you are informed about the risks of treatment with tysabri, including the risk of progressive multifocal leukoencephalopathy (pml). Verify that the patient is currently authorized to receive tysabri prior to each infusion provide the patient with a copy of the patient medication guide prior to each infusion Unified commitment to health phone: Maintain compliance with the touch prescribing program. Web the touch prescribing program has designed to:
